Santen Betimol
Executive Summary
Journal ads will begin Jan. 15 following Santen's reacquisition of marketing rights for the glaucoma ophthalmic solution from CibaVision. Timolol hemihydrate is manufactured by Santen, but has been marketed by Ciba since approval in 1995. Santen expects $10 mil. annually from the drug. Ciba had not been heavily promoting Betimol; Santen will use its 60 reps, who also promote Alamast and Quixin